Sort
82,697 grants matching “vaccine development”
Oral Vaccination for AIDS Prevention in Rhesus Macaques
$704,829Anna Aldovini · Boston Children'S Hospital · R01 · FY2009 · DE
Structure and Function of Flaviviruses
$704,801Michael G Rossmann · Purdue University · R01 · FY2011 · AI
PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION
$704,735Adriana Weinberg · University Of Colorado Denver · U01 · FY2024 · AI
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node
$704,645Michael R Betts · University Of Pennsylvania · R01 · FY2015 · AI
Regulation of CD8+ T cell immunity to tuberculosis
$704,580Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Regulation of CD8+ T cell immunity to tuberculosis
$704,580Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
Regulation of CD8+ T cell immunity to tuberculosis
$704,580Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
Regulation of CD8+ T cell immunity to tuberculosis
$704,580Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to Infection
$704,567Jodie Ann Dionne · University Of Alabama At Birmingham · R01 · FY2023 · AI
A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis
$704,565Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2025 · DK
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry
$704,553Richard M Longnecker · Northwestern University At Chicago · R01 · FY2021 · AI
Development of novel endosome-targeted Ebola virus entry inhibitors as antiviral agents
$704,548Matteo Porotto · Columbia University Health Sciences · R01 · FY2016 · AI
Mycobacterial Genes, Antigens, and Vaccines
$704,511Harvard University (Sch Of Public Hlth) · R01 · FY2002 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells
$704,472Joel D. Ernst · New York University School Of Medicine · R01 · FY2016 · AI
Infant immunoprophylaxis against a primate lentivirus
$704,456Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · R37 · FY2007 · AI
Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform
$704,453Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2022 · AI
Basic Research Support for the CCR
$704,435Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Lymphoma Studies
$704,359Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Lactoferrin as an Adjuvant for Cellular Immunity
$704,286Pharmareview Corporation · R42 · FY2005 · AI
Online Training and Support for Effective Implementation of RTR
$704,214Regina Firpo-Triplett · Monarch Media, Inc. · R44 · FY2010 · MH
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
$704,163Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2021 · AI
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$704,107Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Predicting protective T-cell responses in Tuberculosis using a systems biology approach
$704,080Denise E Kirschner · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Plant-derived vaccines against hepatitis C Cooperative *
$704,052Charles Joel Arntzen · Arizona State University-Tempe Campus · U19 · FY2006 · AI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry
$704,020Richard M Longnecker · Northwestern University At Chicago · R01 · FY2022 · AI